SOX11 and TP53 add prognostic information to MIPI in a homogenously treated cohort of mantle cell lymphoma--a Nordic Lymphoma Group study. [electronic resource]
Producer: 20140810Description: 98-108 p. digitalISSN:- 1365-2141
- Adolescent
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Biomarkers, Tumor -- metabolism
- Child
- Cohort Studies
- Cyclin D1 -- metabolism
- Female
- Humans
- Lymphoma, Mantle-Cell -- diagnosis
- Male
- Neoplasm Proteins -- metabolism
- Neoplasm Staging
- Prognosis
- SOXC Transcription Factors -- metabolism
- Severity of Illness Index
- Survival Analysis
- Treatment Outcome
- Tumor Suppressor Protein p53 -- metabolism
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.